Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLAND PHARMA vs MANGALAM DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GLAND PHARMA MANGALAM DRUGS GLAND PHARMA/
MANGALAM DRUGS
 
P/E (TTM) x 42.6 52.6 81.1% View Chart
P/BV x 3.4 1.2 276.9% View Chart
Dividend Yield % 1.1 0.0 -  

Financials

 GLAND PHARMA   MANGALAM DRUGS
EQUITY SHARE DATA
    GLAND PHARMA
Mar-24
MANGALAM DRUGS
Mar-24
GLAND PHARMA/
MANGALAM DRUGS
5-Yr Chart
Click to enlarge
High Rs2,196132 1,658.4%   
Low Rs86291 951.4%   
Sales per share (Unadj.) Rs343.9232.8 147.7%  
Earnings per share (Unadj.) Rs46.9-5.7 -818.3%  
Cash flow per share (Unadj.) Rs67.83.5 1,924.3%  
Dividends per share (Unadj.) Rs20.000-  
Avg Dividend yield %1.30-  
Book value per share (Unadj.) Rs529.685.8 617.3%  
Shares outstanding (eoy) m164.7115.83 1,040.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.40.5 928.5%   
Avg P/E ratio x32.6-19.4 -167.6%  
P/CF ratio (eoy) x22.531.6 71.3%  
Price / Book Value ratio x2.91.3 222.2%  
Dividend payout %42.60-   
Avg Mkt Cap Rs m251,7811,764 14,269.7%   
No. of employees `000NANA-   
Total wages/salary Rs m12,569391 3,216.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m56,6473,686 1,536.8%  
Other income Rs m1,7021 173,709.2%   
Total revenues Rs m58,3503,687 1,582.6%   
Gross profit Rs m13,331174 7,662.7%  
Depreciation Rs m3,446147 2,351.8%   
Interest Rs m262139 188.3%   
Profit before tax Rs m11,325-111 -10,228.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,601-20 -17,986.1%   
Profit after tax Rs m7,725-91 -8,514.8%  
Gross profit margin %23.54.7 498.6%  
Effective tax rate %31.818.1 175.9%   
Net profit margin %13.6-2.5 -554.1%  
BALANCE SHEET DATA
Current assets Rs m56,4521,760 3,207.5%   
Current liabilities Rs m13,9841,641 852.3%   
Net working cap to sales %75.03.2 2,314.6%  
Current ratio x4.01.1 376.3%  
Inventory Days Days502 2,214.4%  
Debtors Days Days100277 36.3%  
Net fixed assets Rs m49,6571,577 3,148.8%   
Share capital Rs m165158 104.1%   
"Free" reserves Rs m87,0601,200 7,257.1%   
Net worth Rs m87,2251,358 6,423.3%   
Long term debt Rs m1,065134 797.8%   
Total assets Rs m106,1083,337 3,179.7%  
Interest coverage x44.20.2 21,642.2%   
Debt to equity ratio x00.1 12.4%  
Sales to assets ratio x0.51.1 48.3%   
Return on assets %7.51.5 518.4%  
Return on equity %8.9-6.7 -132.6%  
Return on capital %13.11.9 688.3%  
Exports to sales %63.10-   
Imports to sales %023.6 0.0%   
Exports (fob) Rs m35,764NA-   
Imports (cif) Rs mNA870 0.0%   
Fx inflow Rs m35,7641,689 2,117.1%   
Fx outflow Rs m9,401879 1,069.6%   
Net fx Rs m26,363810 3,253.6%   
CASH FLOW
From Operations Rs m9,96839 25,474.0%  
From Investments Rs m-17,569-118 14,855.1%  
From Financial Activity Rs m-7,99452 -15,294.0%  
Net Cashflow Rs m-15,518-27 57,730.9%  

Share Holding

Indian Promoters % 0.0 50.3 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 39.8 0.1 36,218.2%  
FIIs % 4.5 0.1 4,072.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 49.7 96.9%  
Shareholders   122,358 19,508 627.2%  
Pledged promoter(s) holding % 0.0 10.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GLAND PHARMA With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on GLAND PHARMA vs MANGALAM DRUGS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GLAND PHARMA vs MANGALAM DRUGS Share Price Performance

Period GLAND PHARMA MANGALAM DRUGS S&P BSE HEALTHCARE
1-Day 0.08% -0.05% 0.55%
1-Month 8.68% -5.37% -0.91%
1-Year 4.05% 9.63% 42.66%
3-Year CAGR -20.28% -5.42% 20.08%
5-Year CAGR -0.34% 27.41% 26.07%

* Compound Annual Growth Rate

Here are more details on the GLAND PHARMA share price and the MANGALAM DRUGS share price.

Moving on to shareholding structures...

The promoters of GLAND PHARMA hold a 51.8% stake in the company. In case of MANGALAM DRUGS the stake stands at 50.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GLAND PHARMA and the shareholding pattern of MANGALAM DRUGS.

Finally, a word on dividends...

In the most recent financial year, GLAND PHARMA paid a dividend of Rs 20.0 per share. This amounted to a Dividend Payout ratio of 42.6%.

MANGALAM DRUGS paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of GLAND PHARMA, and the dividend history of MANGALAM DRUGS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Indian Rupee at Record Low | Belrise Industries IPO | Top Buzzing Stocks Today Indian Rupee at Record Low | Belrise Industries IPO | Top Buzzing Stocks Today(Pre-Open)

On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.